The management of myelofibrosis: A British Society for Haematology Guideline

Donal P McLornan; Bethan Psaila; Joanne Ewing; Andrew Innes; Siamak Arami; Jessica Brady; Nauman M Butt; Catherine Cargo; Nicholas C P Cross; Sebastian Francis; Rebecca Frewin; Mamta Garg; Anna L Godfrey; Anna Green; Alesia Khan; Steve Knapper; Jonathan Lambert; Andrew McGregor; Mary Frances McMullin; Jyoti Nangalia; Pratap Neelakantan; Claire Woodley; Adam Mead; Tim C P Somervaille; Claire N Harrison; BSH Committee

doi:10.1111/bjh.19186

The management of myelofibrosis: A British Society for Haematology Guideline

Donal P McLornan, Bethan Psaila, Joanne Ewing, Andrew Innes, Siamak Arami, Jessica Brady, Nauman M Butt, Catherine Cargo, Nicholas C P Cross, Sebastian Francis, Rebecca Frewin, Mamta Garg, Anna L Godfrey, Anna Green, Alesia Khan, Steve Knapper, Jonathan Lambert, Andrew McGregor, Mary Frances McMullin, Jyoti NangaliaPratap Neelakantan, Claire Woodley, Adam Mead, Tim C P Somervaille, Claire N Harrison, BSH Committee

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

15 Downloads (Pure)

Abstract

This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015.1 These guidelines aim to provide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF), as well as postpolycythaemia myelofibrosis (post-PV MF) and postessential thrombocythaemia myelofibrosis (post-ET MF). A separate BSH guideline covers the diagnosis and prognostic evaluation of myelofibrosis and is published alongside this guideline.

Original language	English
Journal	British Journal of Haematology
Early online date	01 Dec 2023
DOIs	https://doi.org/10.1111/bjh.19186
Publication status	Early online date - 01 Dec 2023

Access to Document

10.1111/bjh.19186Licence: Unspecified

The management of myelofibrosis: A British Society for Haematology Guideline
Copyright 2023 British Society for Haematology and John Wiley & Sons Ltd. This work is made available online in accordance with the publisher’s policies. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 266 KBLicence: Unspecified

Cite this

McLornan, D. P., Psaila, B., Ewing, J., Innes, A., Arami, S., Brady, J., Butt, N. M., Cargo, C., Cross, N. C. P., Francis, S., Frewin, R., Garg, M., Godfrey, A. L., Green, A., Khan, A., Knapper, S., Lambert, J., McGregor, A., McMullin, M. F., ... BSH Committee (2023). The management of myelofibrosis: A British Society for Haematology Guideline. British Journal of Haematology. Advance online publication. https://doi.org/10.1111/bjh.19186

@article{9427b86656f64b1babec7c544a0f49cb,

title = "The management of myelofibrosis: A British Society for Haematology Guideline",

abstract = "This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015.1 These guidelines aim to provide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF), as well as postpolycythaemia myelofibrosis (post-PV MF) and postessential thrombocythaemia myelofibrosis (post-ET MF). A separate BSH guideline covers the diagnosis and prognostic evaluation of myelofibrosis and is published alongside this guideline.",

author = "McLornan, {Donal P} and Bethan Psaila and Joanne Ewing and Andrew Innes and Siamak Arami and Jessica Brady and Butt, {Nauman M} and Catherine Cargo and Cross, {Nicholas C P} and Sebastian Francis and Rebecca Frewin and Mamta Garg and Godfrey, {Anna L} and Anna Green and Alesia Khan and Steve Knapper and Jonathan Lambert and Andrew McGregor and McMullin, {Mary Frances} and Jyoti Nangalia and Pratap Neelakantan and Claire Woodley and Adam Mead and Somervaille, {Tim C P} and Harrison, {Claire N} and {BSH Committee}",

year = "2023",

month = dec,

day = "1",

doi = "10.1111/bjh.19186",

language = "English",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons Inc.",

}

McLornan, DP, Psaila, B, Ewing, J, Innes, A, Arami, S, Brady, J, Butt, NM, Cargo, C, Cross, NCP, Francis, S, Frewin, R, Garg, M, Godfrey, AL, Green, A, Khan, A, Knapper, S, Lambert, J, McGregor, A, McMullin, MF, Nangalia, J, Neelakantan, P, Woodley, C, Mead, A, Somervaille, TCP, Harrison, CN & BSH Committee 2023, 'The management of myelofibrosis: A British Society for Haematology Guideline', British Journal of Haematology. https://doi.org/10.1111/bjh.19186

TY - JOUR

T1 - The management of myelofibrosis: A British Society for Haematology Guideline

AU - McLornan, Donal P

AU - Psaila, Bethan

AU - Ewing, Joanne

AU - Innes, Andrew

AU - Arami, Siamak

AU - Brady, Jessica

AU - Butt, Nauman M

AU - Cargo, Catherine

AU - Cross, Nicholas C P

AU - Francis, Sebastian

AU - Frewin, Rebecca

AU - Garg, Mamta

AU - Godfrey, Anna L

AU - Green, Anna

AU - Khan, Alesia

AU - Knapper, Steve

AU - Lambert, Jonathan

AU - McGregor, Andrew

AU - McMullin, Mary Frances

AU - Nangalia, Jyoti

AU - Neelakantan, Pratap

AU - Woodley, Claire

AU - Mead, Adam

AU - Somervaille, Tim C P

AU - Harrison, Claire N

AU - BSH Committee

PY - 2023/12/1

Y1 - 2023/12/1

N2 - This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015.1 These guidelines aim to provide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF), as well as postpolycythaemia myelofibrosis (post-PV MF) and postessential thrombocythaemia myelofibrosis (post-ET MF). A separate BSH guideline covers the diagnosis and prognostic evaluation of myelofibrosis and is published alongside this guideline.

AB - This document represents an update of the British Society for Haematology guideline on Myelofibrosis first published in 2012 and updated in 2015.1 These guidelines aim to provide healthcare professionals with clear guidance on stratified management for primary myelofibrosis (PMF), as well as postpolycythaemia myelofibrosis (post-PV MF) and postessential thrombocythaemia myelofibrosis (post-ET MF). A separate BSH guideline covers the diagnosis and prognostic evaluation of myelofibrosis and is published alongside this guideline.

U2 - 10.1111/bjh.19186

DO - 10.1111/bjh.19186

M3 - Article

C2 - 38037886

SN - 0007-1048

JO - British Journal of Haematology

JF - British Journal of Haematology

ER -

The management of myelofibrosis: A British Society for Haematology Guideline

Abstract

Access to Document

Fingerprint

Cite this